Maravai Lifesciences Holdings Inc. (MRVI)
NASDAQ · Healthcare
Maravai Lifesciences Holdings Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 185.7M | 259.2M | 288.9M | 883.0M | 799.2M | 284.1M |
| Gross Profit | 34.0M | 108.3M | 140.2M | 714.0M | 658.7M | 204.4M |
| Profitability | ||||||
| Operating Income | -128.5M | -72.7M | -28.5M | 566.4M | 543.4M | 100.9M |
| EBITDA | -60.8M | 9.2M | 715.6M | 602.4M | 583.3M | 126.9M |
| Net Income | -230.8M | -259.6M | -138.4M | 490.7M | 469.3M | 78.8M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.90 | $-1.05 | $-0.90 | $1.67 | $1.56 | $2.36 |
| Shares Outstanding (dil.) | 144M | 138M | 132M | 132M | 115M | 10M |
Maravai Lifesciences Holdings Inc. Income Statement — FAQ
Maravai Lifesciences Holdings Inc. (MRVI) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRVI's income statement history?
The chart and table above show Maravai Lifesciences Holdings Inc.'s income statement by year and by quarter, including the growth rate.